Top Industry Leaders in the Hirsutism Treatment Market
Latest Hirsutism Treatment Companies Updates:
Elnora Pharmaceuticals Inc. (US) Received FDA approval for its VIOKAL™ (elagolix), a once-daily oral medication for the treatment of moderate-to-severe hirsutism in women with androgen excess (Jan 2024).
Bayer AG (Germany) Announced positive Phase 3 data for its investigational oral androgen receptor antagonist (OAR), KAE-779, for the treatment of hirsutism in women with PCOS (Dec 2023).
Lutronic Corporation (South Korea) Launched its SpectraLite Versa™ IPL hair removal system for professional and home use, offering a safe and effective option for managing unwanted hair growth associated with hirsutism (Nov 2023).
Candela Corporation (US) Introduced its GentleMax Pro Plus® laser system with advanced features for permanent hair reduction, catering to the growing demand for minimally invasive hirsutism treatments (Oct 2023).
List of Hirsutism Treatment Key companies in the market:
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- Jubilant Cadista (US)
- Pfizer Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)